Titan America SA Common Shares (TTAM)
16.92
+0.41 (2.48%)
NYSE · Last Trade: Dec 11th, 11:59 PM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025

